Supraventricular tachycardia AHA recommendations for Management of SVT of Unknown Mechanism: Difference between revisions
Aysha Aslam (talk | contribs) |
Aysha Aslam (talk | contribs) |
||
Line 25: | Line 25: | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''4.'''Synchronized cardioversion is recommended for acute treatment in patients with hemodynamically stable SVT when pharmacological therapy is ineffective or contraindicated <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B-NR]])'' <nowiki>"</nowiki> | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''4.'''Synchronized cardioversion is recommended for acute treatment in patients with hemodynamically stable SVT when pharmacological therapy is ineffective or contraindicated <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B-NR]])'' <nowiki>"</nowiki> | ||
|} | |} | ||
Line 38: | Line 36: | ||
|- | |- | ||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''2.''' Intravenous beta blockers are reasonable for acute treatment in patients with hemodynamically stable SVT <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C-LD]])'' <nowiki>"</nowiki> | |bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''2.''' Intravenous beta blockers are reasonable for acute treatment in patients with hemodynamically stable SVT <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C-LD]])'' <nowiki>"</nowiki> | ||
|- | |- | ||
|} | |} | ||
Revision as of 18:33, 25 October 2016
Resident Survival Guide |
Supraventricular tachycardia Microchapters |
Differentiating Among the Different Types of Supraventricular Tachycardia |
---|
Differentiating Supraventricular Tachycardia from Ventricular Tachycardia |
Diagnosis |
Treatment |
2015 ACC/AHA Guideline Recommendations |
Case Studies |
Supraventricular tachycardia AHA recommendations for Management of SVT of Unknown Mechanism On the Web |
American Roentgen Ray Society Images of Supraventricular tachycardia AHA recommendations for Management of SVT of Unknown Mechanism |
FDA on Supraventricular tachycardia AHA recommendations for Management of SVT of Unknown Mechanism |
CDC on Supraventricular tachycardia AHA recommendations for Management of SVT of Unknown Mechanism |
Blogs on Supraventricular tachycardia AHA recommendations for Management of SVT of Unknown Mechanism |
Directions to Hospitals Treating Supraventricular tachycardia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Aysha Anwar, M.B.B.S[2]
Overview
Management of SVT of Unknown Mechanism
Class I |
"1.Vagal maneuvers are recommended for acute treatment in patients with regular SVT "(Level of Evidence: B-R) " |
"2.Adenosine is recommended for acute treatment in patients with regular SVT </nowiki>"</nowiki>(Level of Evidence: B-R) " |
"3.Synchronized cardioversion is recommended for acute treatment in patients with hemodynamically unstable SVT when vagal maneuvers or adenosine are ineffective or not feasible " (Level of Evidence: B-NR) " |
"4.Synchronized cardioversion is recommended for acute treatment in patients with hemodynamically stable SVT when pharmacological therapy is ineffective or contraindicated "(Level of Evidence: B-NR) " |
Class IIa |
"1. Intravenous diltiazem or verapamil can be effective for acute treatment in patients with hemodynamically stable SVT "(Level of Evidence:B-R) "
|
"2. Intravenous beta blockers are reasonable for acute treatment in patients with hemodynamically stable SVT "(Level of Evidence: C-LD) " |